dm+d
60881009
Articles
Diamorphine hydrochloride products: information for supporting intrathecal risk assessment
11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Supply and/or administration of Controlled Drugs under a PGD
16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.
Medicine Compliance Aid Stability
genericAurum Pharmaceuticals Ltd
Aurum Pharmaceuticals Ltd
generic
Tablets 10mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light.
3 April 2022
Lactation Safety Information
For pain
For pain
Morphine
No published evidence of safety
Risk of serious adverse effects in breastfed infants
Infant monitoring advised, especially in young infants (see summary)
30 July 2020